Clinical Trials Logo

Clinical Trial Summary

Brain tumors are the second most frequent malignant diseases in children and adolescents. In the study the short and medium term consequences of proton therapy on cognitive processes in particular on executive functions in pediatric patients shall be highlighted/analysed/evalutated. In a second step, these results are to be compared with 1. a group of children and adolescents who had only /exclusively had operative therapy and 2. with a healthy control group. Thus, the extent to which these treatment options differ in terms of their short and medium-term effect is assessed. Methods of neurocognitive/neurophysiology brain research approaches are applied that may potentially visualize even small / subtle changes in mental activities/neurocognitive function. Therefore the effects of treatment can be evaluated and the neuropsychological outcome of children and adolescents with brain tumors can be improved.


Clinical Trial Description

Radio(chemo)therapy with protons is conducted according to current treatment standards or, for patients participating in a clinical intervention study, according to the study protocols of the GPOH. Only patients with prescribed radiation doses > 40 Gy (RBE) will be included. Treatment planning, the target volume and radiotherapy will be performed according to the current treatment standards. For patients participating in a clinical intervention study, radiotherapy is corresponding to study protocol of the GPOH. Risk organs (e.g. brain stem, chiasma, optic nerves, gll. Lacrimals, lenses, inner ears and spine) are contoured and the radiation doses for these organs are limited according to institutional guidelines. Radiotherapy is performed according to guidelines, i.e. 5 days a week for 4-6 weeks, usually on an outpatient basis. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT04066465
Study type Observational
Source Technische Universität Dresden
Contact Mechthild Krause, Prof. Dr.
Phone +49 351 458 2238
Email mechthild.krause@uniklinikum-dresden.de
Status Recruiting
Phase
Start date September 1, 2019
Completion date December 31, 2027

See also
  Status Clinical Trial Phase
Recruiting NCT05539677 - Biobank and Register of Patients With Agresive Tumors for Translational and Analytical Research
Completed NCT02392078 - Laser Ablation of Abnormal Neurological Tissue Using Robotic NeuroBlate System
Not yet recruiting NCT02272452 - Assistance in Neurosurgery (ExtempoRMN) N/A
Recruiting NCT06104488 - A Study of Avutometinib for People With Solid Tumor Cancers Phase 1
Completed NCT02338037 - Neuropharmacokinetics of Eribulin Mesylate in Treating Patients With Primary or Metastatic Brain Tumors Early Phase 1
Completed NCT05328739 - The Effect of Home Care Planned According to Orem in Patients With Primary Brain Tumor and Their Caregivers N/A
Completed NCT02034708 - Efficacy Evaluation of Dotarem®-Enhanced MRI Compared to Gadovist®/Gadavist®-Enhanced MRI in the Diagnosis of Brain Tumors Phase 4
Terminated NCT00629395 - Computerized Cognitive Training for Childhood Cancer Survivors N/A
Completed NCT04919993 - CBT for Insomnia in Primary Brain Tumor Patients N/A
Completed NCT04075370 - Exploring Compensation to Maintain Cognitive Function in Adults Newly Diagnosed With Brain Cancer
Completed NCT01242566 - Temozolomide in Elderly Patients With KPS < 70 Phase 2
Not yet recruiting NCT06439420 - CBT-I in Primary Brain Tumor Patients: Phase IIc Randomized Feasibility Pilot Trial Phase 2
Recruiting NCT01535430 - Assessment of Eloquent Function in Brain Tumor Patients
Completed NCT00285324 - Diffusion Tensor MRI to Distinguish Brain Tumor Recurrence From Radiation Necrosis N/A
Recruiting NCT03684109 - Non-invasive Glioma Characterization Through Molecular Imaging N/A
Recruiting NCT05576103 - Longitudinal Prospective Study of Neurocognition & Neuroimaging in Primary BT Patients
Not yet recruiting NCT00265174 - Serum DNA Analysis: Potential Application for Diagnosis and Prognosis in Brain Cancer. N/A
Recruiting NCT05106296 - Chemo-immunotherapy Using Ibrutinib Plus Indoximod for Patients With Pediatric Brain Cancer Phase 1
Completed NCT04118426 - Cognitive Function After Radiation Therapy for Brain Tumours
Recruiting NCT02693405 - Executive and Socio-cognitive Functions in Survivors of Primary Brain Tumor: Impact on Patients' Quality of Life N/A